Mathis W, Ferrara M, Cahill J, Karmani S, Tayfur S, Srihari V
PLoS One. 2024; 19(7):e0302116.
PMID: 39028697
PMC: 11259254.
DOI: 10.1371/journal.pone.0302116.
Tiller J, Maguire T, Newman-Taylor K
Eur Psychiatry. 2023; 66(1):e92.
PMID: 37929296
PMC: 10755576.
DOI: 10.1192/j.eurpsy.2023.2465.
Ruiz de Miras J, Ibanez-Molina A, Soriano M, Iglesias-Parro S
Front Hum Neurosci. 2023; 17:1236832.
PMID: 37799187
PMC: 10547874.
DOI: 10.3389/fnhum.2023.1236832.
Baeza I, de la Serna E, Mezquida G, Cuesta M, Vieta E, Amoretti S
Eur Child Adolesc Psychiatry. 2023; 33(3):799-810.
PMID: 37027026
PMC: 10894175.
DOI: 10.1007/s00787-023-02196-7.
Sulku S, Tokatlioglu Y, Cosar K
BMC Public Health. 2023; 23(1):208.
PMID: 36721134
PMC: 9887775.
DOI: 10.1186/s12889-023-15135-7.
A review on status of incarcerated prisoners with an unsound mind and need for remedies to protect their constitutional rights.
Kathane P, Tripathi M, Tiwari S
Indian J Psychiatry. 2023; 64(6):540-544.
PMID: 36714664
PMC: 9881717.
DOI: 10.4103/indianjpsychiatry.indianjpsychiatry_390_21.
Granular analysis of pathways to care and durations of untreated psychosis: A marginal delay model.
Mathis W, Ferrara M, Burke S, Hyun E, Li F, Zhou B
PLoS One. 2022; 17(12):e0270234.
PMID: 36472968
PMC: 9725156.
DOI: 10.1371/journal.pone.0270234.
The mood disorder spectrum vs. schizophrenia decision tree: EDIPHAS research into the childhood and adolescence of 205 patients.
Leger M, Wolff V, Kabuth B, Albuisson E, Ligier F
BMC Psychiatry. 2022; 22(1):194.
PMID: 35300648
PMC: 8932125.
DOI: 10.1186/s12888-022-03835-0.
Reducing the Duration of Untreated Psychosis (DUP) in a US Community: A Quasi-Experimental Trial.
Srihari V, Ferrara M, Li F, Kline E, Guloksuz S, Pollard J
Schizophr Bull Open. 2022; 3(1):sgab057.
PMID: 35295656
PMC: 8919192.
DOI: 10.1093/schizbullopen/sgab057.
The Perspectives of Early Diagnosis of Schizophrenia Through the Detection of Epigenomics-Based Biomarkers in iPSC-Derived Neurons.
Lee D, Seo J, Chan Jeong H, Lee H, Lee S
Front Mol Neurosci. 2021; 14:756613.
PMID: 34867186
PMC: 8633873.
DOI: 10.3389/fnmol.2021.756613.
Efficacy and tolerability of aripiprazole versus D antagonists in the early course of schizophrenia: a systematic review and meta-analysis.
Kim D, Barr A, Lian L, Yuen J, Fredrikson D, Honer W
NPJ Schizophr. 2021; 7(1):29.
PMID: 34035313
PMC: 8149726.
DOI: 10.1038/s41537-021-00158-z.
Duration of Untreated Psychosis in First-Episode Psychosis is not Associated With Common Genetic Variants for Major Psychiatric Conditions: Results From the Multi-Center EU-GEI Study.
Ajnakina O, Rodriguez V, Quattrone D, Di Forti M, Vassos E, Arango C
Schizophr Bull. 2021; 47(6):1653-1662.
PMID: 33963865
PMC: 8562562.
DOI: 10.1093/schbul/sbab055.
The clinical significance of duration of untreated psychosis: an umbrella review and random-effects meta-analysis.
Howes O, Whitehurst T, Shatalina E, Townsend L, Onwordi E, Mak T
World Psychiatry. 2021; 20(1):75-95.
PMID: 33432766
PMC: 7801839.
DOI: 10.1002/wps.20822.
White matter integrity, duration of untreated psychosis, and antipsychotic treatment response in medication-naïve first-episode psychosis patients.
Kraguljac N, Anthony T, Morgan C, Jindal R, Burger M, Lahti A
Mol Psychiatry. 2020; 26(9):5347-5356.
PMID: 32398721
PMC: 7658031.
DOI: 10.1038/s41380-020-0765-x.
Results of a prospective, mixed methods study to assess feasibility, acceptability and effectiveness of TRIumPH (Treatment and Recovery In PsycHosis): an integrated care pathway for psychosis, compared to usual treatment.
Rathod S, Thorne K, Graves E, Phiri P, Asher C, Griffiths A
BMJ Open. 2020; 10(4):e033711.
PMID: 32354777
PMC: 7213857.
DOI: 10.1136/bmjopen-2019-033711.
Similarities and Differences in Associations Between Duration of Untreated Psychosis (DUP) and Demographic, Premorbid, and Symptom Severity Measures in Two Samples of First-Episode Psychosis Patients from Mexico and the United States.
Fresan A, Apiquian R, Robles-Garcia R, Zarate C, Balducci P, Broussard B
Psychiatr Q. 2020; 91(3):769-781.
PMID: 32221766
PMC: 7780290.
DOI: 10.1007/s11126-020-09736-3.
Trajectory and early predictors of apathy development in first-episode psychosis and healthy controls: a 10-year follow-up study.
Lyngstad S, Gardsjord E, Engen M, Haatveit B, Ihler H, Wedervang-Resell K
Eur Arch Psychiatry Clin Neurosci. 2020; 270(6):709-722.
PMID: 32130475
PMC: 7423800.
DOI: 10.1007/s00406-020-01112-3.
Lead-Time Bias Confounds Association Between Duration of Untreated Psychosis and Illness Course in Schizophrenia.
Jonas K, Fochtmann L, Perlman G, Tian Y, Kane J, Bromet E
Am J Psychiatry. 2020; 177(4):327-334.
PMID: 32046533
PMC: 10754034.
DOI: 10.1176/appi.ajp.2019.19030324.
Early and very early-onset schizophrenia compared with adult-onset schizophrenia: French FACE-SZ database.
Coulon N, Godin O, Bulzacka E, Dubertret C, Mallet J, Fond G
Brain Behav. 2020; 10(2):e01495.
PMID: 31908151
PMC: 7010576.
DOI: 10.1002/brb3.1495.
Specificity of Childhood Trauma Type and Attenuated Positive Symptoms in a Non-Clinical Sample.
Ered A, Ellman L
J Clin Med. 2019; 8(10).
PMID: 31557792
PMC: 6832238.
DOI: 10.3390/jcm8101537.